Table 2.
Results for pelvic Irradiation with IMRT in terms of local failure, disease free survival, and overall survival.
| Author/year | n | Patients | Technique | Field | Planning target volume | Dose | Follow-up (median) | Local failure | Distant failure |
|---|---|---|---|---|---|---|---|---|---|
| Chen 200711 | 68 | Cervix Adjuvant | 4Fb vs IMRTa | Pelvic | na | 50.4 Gy | 14 m | EBRT: 4F 6% IMRT: 7% |
|
| Beriwal 200721 | 36 | Cervix Ib2-IVa | IMRT | Pelvic + parac | CTV 0.5 + 1 cm | 45 Gy | 18 m | ||
| Kidd 201025 | 452 | Cervix Ia-IVb PET CT staging |
IMRT or 3Dc + HDR/LDR | PET positive Para, pelvic+ para | CTVd +7 mm | 50.4 Gy | 52 m | IMRT 8.1% 3Dce 10.4% p value ns |
IMRT 15.6% 3Dc 24.6% p value ns |
| Chen 201120 | 109 | Cervix IB2-IVA | IMRT + BTf | Pelvic | CTV + 0.7–1 cm | 50.4–54 Gy | 32 m | 13.8% 3 years | 22% |
| Hasselle 201122 | 111 | Cervix I-IVA Radical and Adjuvant | IMRT + HDR – BTg | Pelvic | CTV + 0.7–1 cm | 45 Gy | 27 m | 14%@ 3 years | 17% @ 3years |
| Zhang 1224 | 58 | Cervix I-II Adjuvant | IMRT – Para | Pelvic + Para | CTV +1 cm | 50.4 Gy | 34 m | 3.4% | 27% |
Intensity modulated radiation therapy.
External beam radiotherapy 4 fields.
Paraortic field.
Clinical target volume.
3D conformal.
Brachytherapy.
High dose rate brachytherapy.